-
HC Wainwright Reaffirms "Buy" Rating for Barinthus Biotherapeutics (NASDAQ:BRNS)
Source: Buzz FX / 09 Nov 2024 15:11:18 America/New_York
HC Wainwright Reaffirms "Buy" Rating for Barinthus Biotherapeutics (NASDAQ:BRNS) Written by MarketBeat November 9, 2024 Share Link copied to clipboard. Barinthus Biotherapeutics ( NASDAQ:BRNS - Get Free Report ) 's stock had its "buy" ratin
Read more...